Latest Ratios: P/E Ratio -33.5x · EV/EBITDA N/A · ROE -6.3%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $53M | $21M | $30M | $30M | $37M | $28M | $24M | $21M | $23M | $74M | $55M |
| Enterprise Value | $45M | $13M | $18M | $16M | $23M | $13M | $30M | $25M | $25M | $73M | $36M |
| P/E Ratio → | -33.50 | — | — | — | — | 5.82 | — | — | — | 14.17 | — |
| P/S Ratio | 2.07 | 0.82 | 1.12 | 1.25 | 1.44 | 1.68 | 1.43 | 1.08 | 0.95 | 1.80 | 2.60 |
| P/B Ratio | 2.14 | 0.86 | 1.19 | 1.15 | 1.26 | 0.95 | 1.00 | 0.71 | 0.63 | 1.83 | 1.59 |
| P/FCF | — | — | — | — | — | — | — | — | — | — | 6.24 |
| P/OCF | — | — | — | — | 191.26 | — | — | 37.02 | 45.56 | — | 6.16 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.49 | 0.66 | 0.68 | 0.90 | 0.78 | 1.79 | 1.25 | 1.01 | 1.78 | 1.73 |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | 9.07 | 337.55 |
| EV / EBIT | — | — | — | — | — | 2.54 | — | — | — | 10.16 | — |
| EV / FCF | — | — | — | — | — | — | — | — | — | — | 4.14 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 28.3% | 28.3% | 23.6% | 21.0% | 25.7% | 18.7% | 17.0% | 14.2% | 21.3% | 42.8% | 33.9% |
| Operating Margin | -6.8% | -6.8% | -9.0% | -20.2% | -7.1% | -28.4% | -46.2% | -25.4% | -21.6% | 17.6% | -3.5% |
| Net Profit Margin | -6.1% | -6.1% | -7.1% | -17.3% | -0.9% | 28.9% | -35.9% | -32.2% | -21.4% | 12.8% | -0.7% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -6.3% | -6.3% | -7.4% | -15.0% | -0.8% | 17.8% | -22.5% | -19.1% | -13.5% | 14.0% | -0.4% |
| ROA | -5.4% | -5.4% | -5.7% | -11.5% | -0.6% | 12.4% | -13.9% | -12.8% | -9.3% | 10.1% | -0.3% |
| ROIC | -9.0% | -9.0% | -14.2% | -26.2% | -9.2% | -15.7% | -18.5% | -10.5% | -10.2% | 19.4% | -2.7% |
| ROCE | -6.9% | -6.9% | -9.3% | -17.4% | -6.2% | -14.0% | -19.9% | -11.1% | -10.3% | 15.9% | -2.0% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.06 | 0.57 | 0.40 | 0.35 | 0.33 | 0.10 |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | 1.65 | 30.49 |
| Net Debt / Equity | — | -0.35 | -0.49 | -0.52 | -0.47 | -0.51 | 0.25 | 0.11 | 0.04 | -0.02 | -0.54 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | -0.11 | -171.92 |
| Debt / FCF | — | — | — | — | — | — | — | — | — | — | -2.11 |
| Interest Coverage | -120.69 | -120.69 | -97.63 | -181.35 | -26.50 | 19.30 | -16.11 | -9.18 | -11.00 | 67.92 | -7.18 |
Net cash position: cash ($9M) exceeds total debt ($181000)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.06 | 6.06 | 3.26 | 2.67 | 2.90 | 3.64 | 3.18 | 2.63 | 4.78 | 5.13 | 3.46 |
| Quick Ratio | 5.50 | 5.50 | 2.91 | 2.15 | 2.59 | 3.45 | 2.88 | 2.31 | 4.32 | 4.58 | 3.07 |
| Cash Ratio | 3.14 | 3.14 | 2.05 | 1.64 | 1.76 | 2.63 | 2.08 | 1.61 | 2.81 | 2.62 | 2.60 |
| Asset Turnover | — | 0.94 | 0.85 | 0.69 | 0.68 | 0.46 | 0.41 | 0.42 | 0.46 | 0.70 | 0.46 |
| Inventory Turnover | 11.80 | 11.80 | 9.71 | 4.27 | 7.56 | 10.91 | 12.49 | 9.86 | 10.29 | 7.93 | 4.21 |
| Days Sales Outstanding | — | 80.75 | 59.42 | 53.14 | 84.25 | 104.30 | 33.26 | 56.82 | 81.34 | 92.79 | 55.81 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | 17.2% | — | — | — | 7.1% | — |
| FCF Yield | — | — | — | — | — | — | — | — | — | — | 16.0% |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $6M | $6M |
Operational scale and volatility
Based on current market data, CVV trades at a price-to-sales multiple of 1.75, which appears to reflect significant investor skepticism regarding the company's ability to return to profitability, especially when compared to the broader industrial machinery sector's historical valuation premiums for specialized deposition equipment manufacturers.
The negative P/E ratio of -28.35 highlights the absence of earnings support for the current share price, suggesting that the market is pricing the company primarily on its asset base rather than its growth prospects. Investors should monitor whether the current P/B of 1.81 provides a valuation floor or if further margin erosion will necessitate a downward re-rating of the equity.
As reported in recent financial statements, the company's ROIC has trended into negative territory, reaching -8.7% in 2026Q1, which indicates that the firm is currently destroying shareholder value rather than compounding it through its specialized lab-to-fab equipment and material coating operations.
The persistent decline in ROIC from positive levels in 2025 suggests that the company's fixed-cost base is not being adequately leveraged by its current project volume. This trend warrants further investigation into whether the firm's R&D investments are yielding the expected commercialization milestones or if they are merely inflating the cost structure without corresponding revenue growth.
According to quarterly filings, the cash conversion cycle has expanded to 100 days in 2026Q1, reflecting increased friction in the company's ability to convert its specialized inventory into cash, a trend that appears to be exacerbated by the lumpy nature of its project-based revenue recognition.
The rise in DSO and DIO suggests that the company may be facing delays in project milestones or customer acceptance, which directly impacts liquidity. This inefficiency in working capital management appears to be a structural challenge that limits the firm's ability to self-fund its operations during periods of low demand.
Based on the latest balance sheet data, the current ratio of 5.35 remains high, yet this figure is somewhat misleading as it masks the rapid consumption of cash reserves, which have declined significantly over the past ten quarters to fund ongoing operational losses.
While the company maintains a strong current ratio, the lack of consistent operating cash flow suggests that this liquidity is not a result of operational success but rather a reflection of a shrinking business footprint. Investors should monitor the cash burn rate closely, as the current trajectory may eventually force a reliance on external financing if revenue does not stabilize.
The most commonly misapplied metric for CVV is EBITDA, which frequently obscures the company's true operational viability by ignoring the significant and recurring impact of stock-based compensation and the necessity of capital expenditures to maintain its specialized manufacturing facility in Central Islip.
Using EBITDA to evaluate this business model is problematic because it fails to account for the cash-intensive nature of the company's R&D and the lumpy revenue recognition inherent in long-term contracts. Analysts should instead focus on free cash flow and the backlog conversion rate to better assess the firm's ability to sustain its operations without further diluting shareholders.
Includes 30+ ratios · 30 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CVV stock.
CVD Equipment Corporation's current P/E ratio is -33.5x. The historical average is 38.0x.
CVD Equipment Corporation's return on equity (ROE) is -6.3%. The historical average is 3.2%.
Based on historical data, CVD Equipment Corporation is trading at a P/E of -33.5x. Compare with industry peers and growth rates for a complete picture.
CVD Equipment Corporation has 28.3% gross margin and -6.8% operating margin.